Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Permanent Vaccine Facility Should Be On Standby For Future Pandemics, Moncef Slaoui Says

Jan 15 2021

• By Brenda Sandburg

Related Content

Regeneron Calls For More Government-Funding of Biologic Manufacturing While Defending High Industry Prices

Nov 19 2020

With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says

Dec 01 2020

Pfizer’s COVID Vaccine Raises No Safety Red Flags, But Managing Reactogenicity May Be Practical Challenge

Dec 09 2020

Can GSK Veteran Moncef Slaoui Get COVID-19 Vaccine Development To Warp Speed?

May 15 2020

Related Companies

Moderna, Inc.

Pfizer Inc.

Johnson & Johnson

Novavax, Inc.

Sanofi

GSK plc

Additional Topics

United States Coronavirus COVID-19 Vaccines Manufacturing Policy BioPharmaceutical

More from Vaccines

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.